Article
A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish.
EMBO reports - 1 Jul 2002
Geling Andrea, Steiner Harald, Willem Michael, Bally-Cuif Laure, Haass Christian
Abstract excerpt
Inhibition of amyloid beta-peptide (Abeta) production by blocking gamma-secretase activity is at present one of the most promising therapeutic strategies to slow progression of Alzheimer's disease pathology. gamma-secretase inhibitors apparently block Abeta generation via interference with presen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
